Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiaki Hirakata

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 15, 2020
Leukotriene B<sub>4</sub> receptors as therapeutic targets for ophthalmic diseasesToshiaki Hirakata, Akira Matsuda, Takehiko Yokomizo
Current Opinion in Allergy and Clinical Immunology|August 30, 2019
The roles of omega-3 fatty acids and resolvins in allergic conjunctivitisToshiaki Hirakata, Takehiko Yokomizo, Akira Matsuda
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2020
Experimental Mouse Models of Ragweed- and Papain-Induced Allergic ConjunctivitisAkira Matsuda, Toshiaki Hirakata, Yosuke Asada, et al.
American Journal of Ophthalmology Case Reports|January 5, 2022
Infliximab recovers central cone dysfunction with normal fundus in a patient with ulcerative colitisMiyako Chiba-Mayumi, Toshiaki Hirakata, Masahiro Yamaguchi, et al.
Frontiers in Ophthalmology|February 23, 2026
<i>CDHR1</i> variants in a Japanese family with inherited retinal dystrophy and intrafamilial phenotypic variabilityToshiaki Hirakata, Dan Gao, Minami Oshima, et al.
Plos One|December 31, 2021
Clinical patterns of rhegmatogenous retinal detachment during the first state of emergency for the COVID-19 pandemic in a Tokyo centerToshiaki Hirakata, Tianxiang Huang, Yoshimune Hiratsuka, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 17, 2016
One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvementToshiaki Hirakata, Kaoru Fujinami, Ken Watanabe, et al.
Scientific Reports|September 15, 2021
Risk factors for macular pucker after rhegmatogenous retinal detachment surgeryToshiaki Hirakata, Yoshimune Hiratsuka, Shutaro Yamamoto, et al.
Retina (Philadelphia, Pa.)|July 25, 2025
Trocar insertion into the pars plana using an intraocular endoscope-holding robotKenta Ashikaga, Yoshihito Sakanishi, Toshiaki Hirakata, et al.
Plos One|May 13, 2025
Short-term real-world outcomes of diabetic macular edema treated with intravitreal faricimabToshiaki Hirakata, Fumihiro Hara, Yuta Nochi, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 15, 2020
Leukotriene B<sub>4</sub> receptors as therapeutic targets for ophthalmic diseasesToshiaki Hirakata, Akira Matsuda, Takehiko Yokomizo
Current Opinion in Allergy and Clinical Immunology|August 30, 2019
The roles of omega-3 fatty acids and resolvins in allergic conjunctivitisToshiaki Hirakata, Takehiko Yokomizo, Akira Matsuda
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2020
Experimental Mouse Models of Ragweed- and Papain-Induced Allergic ConjunctivitisAkira Matsuda, Toshiaki Hirakata, Yosuke Asada, et al.
American Journal of Ophthalmology Case Reports|January 5, 2022
Infliximab recovers central cone dysfunction with normal fundus in a patient with ulcerative colitisMiyako Chiba-Mayumi, Toshiaki Hirakata, Masahiro Yamaguchi, et al.
Frontiers in Ophthalmology|February 23, 2026
<i>CDHR1</i> variants in a Japanese family with inherited retinal dystrophy and intrafamilial phenotypic variabilityToshiaki Hirakata, Dan Gao, Minami Oshima, et al.
Plos One|December 31, 2021
Clinical patterns of rhegmatogenous retinal detachment during the first state of emergency for the COVID-19 pandemic in a Tokyo centerToshiaki Hirakata, Tianxiang Huang, Yoshimune Hiratsuka, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 17, 2016
One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvementToshiaki Hirakata, Kaoru Fujinami, Ken Watanabe, et al.
Scientific Reports|September 15, 2021
Risk factors for macular pucker after rhegmatogenous retinal detachment surgeryToshiaki Hirakata, Yoshimune Hiratsuka, Shutaro Yamamoto, et al.
Retina (Philadelphia, Pa.)|July 25, 2025
Trocar insertion into the pars plana using an intraocular endoscope-holding robotKenta Ashikaga, Yoshihito Sakanishi, Toshiaki Hirakata, et al.
Plos One|May 13, 2025
Short-term real-world outcomes of diabetic macular edema treated with intravitreal faricimabToshiaki Hirakata, Fumihiro Hara, Yuta Nochi, et al.
Pageof 3